NYC Startup Syntimmune Names Former Biogen Exec as New CEO Post author:Sam Post published:January 2, 2018 Post category:BioPharma Syntimmune has appointed Jean-Paul Kress as president and CEO. Source: BioSpace You Might Also Like Safety Concerns Raised as Ionis Pharma's Inotersen Meets Both Primary Endpoints in Late-Stage Study May 14, 2017 Pfizer Gets Incentives to Keep a 250 Employee Workforce in Memphis October 18, 2017 Google's Verily and Novartis AG Jump Into Medicxi's $300 Million Life Science Investment Fund June 14, 2017
Safety Concerns Raised as Ionis Pharma's Inotersen Meets Both Primary Endpoints in Late-Stage Study May 14, 2017
Google's Verily and Novartis AG Jump Into Medicxi's $300 Million Life Science Investment Fund June 14, 2017
